Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception
Status:
Recruiting
Trial end date:
2022-10-30
Target enrollment:
Participant gender:
Summary
This is a randomised controlled trial aimed at comparing the efficacy of levonorgestrel (LNG)
co-administered with piroxicam or placebo for oral emergency contraception (EC). Piroxicam is
a non-steroidal anti-inflammatory drug (NSAID) commonly used as a pain-killer in inflammatory
conditions. Efficacy will be measured as the percentage of pregnancies prevented.